171 related articles for article (PubMed ID: 21691438)
1. Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity.
Moraski GC; Markley LD; Hipskind PA; Boshoff H; Cho S; Franzblau SG; Miller MJ
ACS Med Chem Lett; 2011 Jun; 2(6):466-470. PubMed ID: 21691438
[TBL] [Abstract][Full Text] [Related]
2. Advancement of Imidazo[1,2-
Moraski GC; Markley LD; Cramer J; Hipskind PA; Boshoff H; Bailey M; Alling T; Ollinger J; Parish T; Miller MJ
ACS Med Chem Lett; 2013 Jul; 4(7):675-679. PubMed ID: 23930153
[TBL] [Abstract][Full Text] [Related]
3. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
Moraski GC; Oliver AG; Markley LD; Cho S; Franzblau SG; Miller MJ
Bioorg Med Chem Lett; 2014 Aug; 24(15):3493-8. PubMed ID: 24909079
[TBL] [Abstract][Full Text] [Related]
4. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
[TBL] [Abstract][Full Text] [Related]
5. Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and "Anagrams" Generated Potent Antituberculosis Agents.
Moraski GC; Miller PA; Bailey MA; Ollinger J; Parish T; Boshoff HI; Cho S; Anderson JR; Mulugeta S; Franzblau SG; Miller MJ
ACS Infect Dis; 2015 Feb; 1(2):85-90. PubMed ID: 25984566
[TBL] [Abstract][Full Text] [Related]
6. Identification of
Wu Z; Lu Y; Li L; Zhao R; Wang B; Lv K; Liu M; You X
ACS Med Chem Lett; 2016 Dec; 7(12):1130-1133. PubMed ID: 27994751
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides as Novel Antitubercular Agents.
Tang J; Wang B; Wu T; Wan J; Tu Z; Njire M; Wan B; Franzblauc SG; Zhang T; Lu X; Ding K
ACS Med Chem Lett; 2015 Jul; 6(7):814-8. PubMed ID: 26191372
[TBL] [Abstract][Full Text] [Related]
8. Development of antimycobacterial tetrahydrothieno[2,3-c]pyridine-3-carboxamides and hexahydrocycloocta[b]thiophene-3-carboxamides: Molecular modification from known antimycobacterial lead.
Nallangi R; Samala G; Sridevi JP; Yogeeswari P; Sriram D
Eur J Med Chem; 2014 Apr; 76():110-7. PubMed ID: 24583350
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
[TBL] [Abstract][Full Text] [Related]
10. Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.
Moraski GC; Markley LD; Chang M; Cho S; Franzblau SG; Hwang CH; Boshoff H; Miller MJ
Bioorg Med Chem; 2012 Apr; 20(7):2214-20. PubMed ID: 22391032
[TBL] [Abstract][Full Text] [Related]
11. Identification of Pyrazolo[1,5-
Hu X; Wan B; Liu Y; Shen J; Franzblau SG; Zhang T; Ding K; Lu X
ACS Med Chem Lett; 2019 Mar; 10(3):295-299. PubMed ID: 30891129
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
Lv K; Li L; Wang B; Liu M; Wang B; Shen W; Guo H; Lu Y
Eur J Med Chem; 2017 Sep; 137():117-125. PubMed ID: 28577507
[TBL] [Abstract][Full Text] [Related]
13. Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB.
Li D; Gao N; Zhu N; Lin Y; Li Y; Chen M; You X; Lu Y; Wan K; Jiang JD; Jiang W; Si S
Bioorg Med Chem Lett; 2015 Nov; 25(22):5178-81. PubMed ID: 26459210
[TBL] [Abstract][Full Text] [Related]
14. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP
Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
[TBL] [Abstract][Full Text] [Related]
16. Homology modeling and molecular docking simulation of some novel imidazo[1,2-a]pyridine-3-carboxamide (IPA) series as inhibitors of Mycobacterium tuberculosis.
Abdullahi M; Adeniji SE; Arthur DE; Haruna A
J Genet Eng Biotechnol; 2021 Jan; 19(1):12. PubMed ID: 33474593
[TBL] [Abstract][Full Text] [Related]
17. Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds.
Moraski GC; Deboosère N; Marshall KL; Weaver HA; Vandeputte A; Hastings C; Woolhiser L; Lenaerts AJ; Brodin P; Miller MJ
PLoS One; 2020; 15(1):e0227224. PubMed ID: 31905374
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents.
Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW
J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
[TBL] [Abstract][Full Text] [Related]
20. Pyrazolo[1,5-a]pyridine-3-carboxamide hybrids: Design, synthesis and evaluation of anti-tubercular activity.
Lu X; Tang J; Cui S; Wan B; Franzblauc SG; Zhang T; Zhang X; Ding K
Eur J Med Chem; 2017 Jan; 125():41-48. PubMed ID: 27654393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
